Organization · Private Equity
Ally Bridge Group
Ally Bridge Group is a global healthcare investment management firm specializing in high-impact life science innovation, with offices in New York and Hong Kong. It employs private equity and public equity strategies to address unmet medical needs.
Overview
What Ally Bridge Group does
What Ally Bridge Group is
Ally Bridge Group is a global healthcare investment management firm specializing in high-impact life science innovation, with offices in New York and Hong Kong. It employs private equity and public equity strategies to address unmet medical needs.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Private Equity
- Founded
- Founded in 2013
- Approximate age
- About 13 years
- Structured capabilities
- Funder
- Last reviewed
- March 28, 2026
Official channels
Find Ally Bridge Group elsewhere
Open the official website or a supported primary organization account.
Capability profile
Ally Bridge Group as a funder
Investment thesis
Ally Bridge Group focuses on high-impact life science innovation, aiming to deliver superior risk-adjusted returns while addressing unmet medical needs through a blend of scientific and clinical research with M&A and capital markets expertise.
Focus narrative
Ally Bridge Group invests across the global healthcare industry, utilizing two primary strategies: private equity and public equity. The firm aims to deliver superior risk-adjusted returns while addressing unmet medical needs through a blend of scientific and clinical research with M&A and capital markets expertise.
Focus and fit
- Regions
- Asia · Global · North America
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 8
Portfolio context
Notable portfolio companies include Biobeat, a medical technology company specializing in cuffless ambulatory blood pressure monitoring; SetPoint Medical, focused on neuroimmune modulation therapy for chronic autoimmune diseases; Cardiac Dimensions, which develops the Carillon Mitral Contour System for heart failure treatment; Epicrispr Bio, pioneering gene-modulating therapies for neuromuscular diseases; VitalConnect, offering wearable biosensor technology for patient monitoring; Kestra Medical Technologies, providing a wearable cardioverter defibrillator for cardiac patients; Insightec, developing focused ultrasound technology for treating movement disorders; and WuXi AppTec, which provides R&D and manufacturing services for the pharmaceutical and biotechnology industries.
Common questions
What to know about Ally Bridge Group
Upseed classifies Ally Bridge Group under the Private Equity organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 28, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.